Nadav Kidron

Nadav Kidron

Chief Executive Officer at ORAMED PHARMACEUTICALS INC.

Net worth: 11 M $ as of 30/07/2026

52 year
Health Technology
Commercial Services
Consumer Services

Profile

Mr. Nadav Kidron is a Chairman, President & Chief Executive Officer at Oramed Pharmaceuticals, Inc., a Chairman at MDG Real Estate Global Ltd., a Chairman at Oravax Medical, Inc. and a Member at Israel Bar Association.
He is on the Board of Directors at Lifeward Ltd., Alpha Tau Medical Ltd., Trobix Innovation Ltd. and Israel Advanced Technology Industries.
Mr. Kidron was previously employed as a MD-Institute of Advanced Jewish Studies by Bar-Ilan University.
He also served on the board at Entera Bio Ltd. He received his graduate degree from Bar-Ilan University and an MBA from Bar-Ilan University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
19/07/2026 2,627,022 ( 6.42% ) 11 M $ 30/07/2026
0.05%
28/01/2026 135,700 ( 0.05% ) 203 550 $ 30/07/2026
24/03/2026 7,657 ( 0.27% ) 55 284 $ 30/07/2026
17/03/2026 2,986 ( 0% ) 35 205 $ 30/07/2026

Nadav Kidron active positions

CompaniesPositionStart
ORAMED PHARMACEUTICALS INC. Chief Executive Officer 07/03/2006
ALPHA TAU MEDICAL LTD. Director/Board Member 11/05/2025
LIFEWARD LTD. Director/Board Member 24/03/2026
Corporate Officer/Principal -
Director/Board Member 31/07/2015
Director/Board Member 26/03/2018
Chairman -
Oravax Medical, Inc.
Chairman -

Former positions of Nadav Kidron

CompaniesPositionEnd
ENTERA BIO LTD. Founder 31/12/2015
░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Nadav Kidron's experience

Training of Nadav Kidron

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

60

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Services

Health Technology

Commercial Services

Health Technology

Health Technology

Commercial Services

Finance

Health Technology

Health Technology

Oravax Medical, Inc.